谷氨酰胺分解
下调和上调
谷氨酰胺酶
肾脏疾病
生物
线粒体
癌症研究
内分泌学
氧化磷酸化
转录组
生物能学
内科学
心力衰竭
细胞生物学
肾
肌肉肥大
磷酸化
胞浆
调节器
HEK 293细胞
重编程
氧化应激
激酶
磷酸酶
医学
磷酸肌酸
谷氨酰胺
三磷酸腺苷
信号转导
小发夹RNA
小RNA
溶酶体
化学
恶病质
作者
Linnan Bai,Yi Wang,Lei Zhou,Fenfen Peng,Xiaojiang Zhan,Lidan Hu,Xiao Wang,Ruipeng Wei,Jianbo Qing,Minchao KANG,Xinni Wang,Yiting Zhao,Xinyu Huang,Li Qiuyu,Fei Liu,Huijuan Wu,Xianfeng Wu,Jianhua Mao,Junnan Wu
标识
DOI:10.1038/s41467-026-79129-w
摘要
Left ventricular hypertrophy (LVH) is a major cardiovascular complication of chronic kidney disease (CKD), yet its mechanisms remain poorly understood. Here we show that in preclinical experiments, CKD drives cardiomyocyte metabolic reprogramming characterized by enhanced glutaminolysis and impaired oxidative phosphorylation in male C57BL/6J mice. Integrated transcriptomic and metabolomic analyses identified early upregulation and activation of glutaminase 1 (GLS1) in CKD hearts, while serum-induced GLS1 activity was associated with LV hypertrophic remodeling in a multicenter peritoneal dialysis cohort. Human myocardial samples also showed increased GLS1 expression in CKD. Cardiomyocyte-specific deletion or pharmacological inhibition of GLS1 attenuated CKD-induced hypertrophy in these mouse models. Proteomic and mechanistic analyses further identified phosphate as a major regulator of GLS1 activity and expression. Excessive GLS1 activation increased ammonia production, disrupted mitochondrial respiratory protein expression and redox homeostasis, and reduced bioenergetic efficiency. These findings identify a phosphate–GLS1–glutaminolysis axis linking the uremic milieu to mitochondrial dysfunction and cardiac hypertrophy, and suggest GLS1 as a potential therapeutic target for CKD-associated LVH. Chronic kidney disease often causes heart enlargement, a serious complication whose mechanisms remain unclear. Here, the authors show that excess phosphate activates the metabolic enzyme GLS1, promoting heart enlargement, while blocking GLS1 protects against this effect in male mice.
科研通智能强力驱动
Strongly Powered by AbleSci AI